Brown, Lisle/Cummings’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-110
Closed -$9.31K 615
2024
Q1
$9.31K Hold
110
﹤0.01% 441
2023
Q4
$8.24K Hold
110
﹤0.01% 457
2023
Q3
$7.61K Hold
110
﹤0.01% 435
2023
Q2
$7.99K Hold
110
﹤0.01% 440
2023
Q1
$7.91K Hold
110
﹤0.01% 425
2022
Q4
$8.21K Hold
110
﹤0.01% 405
2022
Q3
$7.21K Buy
+110
New +$8.42K ﹤0.01% 406

Other funds holding CRI

Brown, Lisle/Cummings's CRI Position: Q2 2024 in Review

Brown, Lisle/Cummings sold out of Carter's (CRI) in Q2 2024, closing a stake of 110 shares — an estimated $9.31K sold.

Brown, Lisle/Cummings first reported a position in CRI in Q3 2022 and held it in 7 quarters. The position peaked at $9.31K in Q1 2024. 329 funds tracked by Wall St. Rank hold CRI as of Q2 2024.

  • Brown, Lisle/Cummings reported no remaining Carter's position as of Q2 2024 after selling out during the quarter.
  • Brown, Lisle/Cummings sold 110 Carter's shares in Q2 2024, an estimated $9.31K.
  • Brown, Lisle/Cummings first reported a position in Carter's in Q3 2022 and held it in 7 quarters.
  • Brown, Lisle/Cummings's Carter's position peaked at $9.31K in Q1 2024.
  • 329 funds tracked by Wall St. Rank held Carter's as of Q2 2024.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2024, filed 17 Jul 2024.